Vicora took an important step toward clinical trials of its unique catheter, the Vibrato16
Vicora Inc. is a true homegrown Buffalo commercialization story.
Now the company has taken an important step forward with the completion of a pre-clinical study for proprietary catheter system, the Vibrato, which aims to remove life-threatening blood clots from the upper legs and lungs with enhanced precision and safety.
Completion of the study puts Vicora on a path for its "first in human" pulmonary embolism clinical trial, which will commence later this year.
Read the company's recent announcement here
Last year, Vicora raised $3.5 million in funding to help it complete the design, development and testing required to obtain regulatory approvals and receive FDA clearance. The company is led by CEO Shawn Patterson, a WNY native who had a successful career in commercializing medical devices, and who was recruited back to his hometown to lead the company.
A portfolio company of Buffalo-based Egret Healthcare Ventures, Vicora is based in an emerging medical device commercialization cluster on Northland Avenue on Buffalo's East Side.
